Remko Prevo
Publications by Year
Research Areas
HER2/EGFR in Cancer Research, DNA Repair Mechanisms, RNA modifications and cancer, Cancer, Hypoxia, and Metabolism, Lymphatic System and Diseases
Most-Cited Works
- → Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis(2001)1,744 cited
- → VEGF-D promotes the metastatic spread of tumor cells via the lymphatics(2001)1,245 cited
- → Mouse LYVE-1 Is an Endocytic Receptor for Hyaluronan in Lymphatic Endothelium(2001)478 cited
- Intratumoral lymphangiogenesis and lymph node metastasis in head and neck cancer.(2002)
- → Targeting ATR in vivo using the novel inhibitor VE-822 results in selective sensitization of pancreatic tumors to radiation(2012)358 cited
- → LYVE-1, the lymphatic system and tumor lymphangiogenesis(2001)355 cited
- → Polθ inhibitors elicit BRCA-gene synthetic lethality and target PARP inhibitor resistance(2021)340 cited
- → The novel ATR inhibitor VE-821 increases sensitivity of pancreatic cancer cells to radiation and chemotherapy(2012)243 cited
- → Adenoviral Expression of Vascular Endothelial Growth Factor-C Induces Lymphangiogenesis in the Skin(2001)237 cited
- → Heparan Sulfate-modified CD44 Promotes Hepatocyte Growth Factor/Scatter Factor-induced Signal Transduction through the Receptor Tyrosine Kinase c-Met(1999)227 cited